OMG sciencefromABC7 San Francisco10 months agoAlzheimer's drug that can slow disease gets backing from FDA advisersFDA advisers backed Alzheimer's drug from Eli Lilly, suggesting approval for mild dementia treatment.
US newsfromwww.npr.org10 months agoFDA advisors strongly back new Alzheimer's drug, despite risks and limitationsFDA advisors recommend approval of Alzheimer's drug donanemab for slowing disease progression.
Medicinefromwww.nytimes.com10 months agoA Drug to Slow Alzheimer's Is Finally Available. How Are Patients Faring?The Alzheimer's drug lecanemab offers hope with modest benefits and high risks, as strict criteria determine patient eligibility.
OMG sciencefromABC7 San Francisco10 months agoAlzheimer's drug that can slow disease gets backing from FDA advisersFDA advisers backed Alzheimer's drug from Eli Lilly, suggesting approval for mild dementia treatment.
US newsfromwww.npr.org10 months agoFDA advisors strongly back new Alzheimer's drug, despite risks and limitationsFDA advisors recommend approval of Alzheimer's drug donanemab for slowing disease progression.
Medicinefromwww.nytimes.com10 months agoA Drug to Slow Alzheimer's Is Finally Available. How Are Patients Faring?The Alzheimer's drug lecanemab offers hope with modest benefits and high risks, as strict criteria determine patient eligibility.